A major challenge when it comes to head and neck cancers is the lack of specific symptoms, which are often overlooked. As a result, diagnoses can occur at advanced stages when treatment becomes ...

The two phase 2 studies, presented at the 2024 American Society for Radiation Oncology (ASTRO) Head and Neck Cancer Symposium on March 1, 2024, found an increase in 1-year local control rate ...

"Head and Neck cancers take up a big chunk of overall rise in cancer cases around the world. According to the GLOBOCAN data report, India is expected to see a rise of 2.1 million cancer cases by ...

Key Takeaways Keytruda is approved for resectable locally advanced head and neck squamous cell carcinoma with PD-L1 expression, marking a significant advancement in treatment options. The KEYNOTE-689 ...

Pharma Merck's Keytruda wins breakthrough head and neck cancer nod around surgery, but with a limitation By Angus Liu Jun 13, 2025 10:50am Merck & Co. Keytruda head and neck cancer PD-1/L1 ...